F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 64,262 shares at $23.00 ($1.4M) on 2023-02-07, disclosed to the SEC on 2023-02-09.
Open-market sale of $1.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 8,800 | $202K | 14.4% |
| 2 | $21.71 | 27,731 | $602K | 42.8% |
| 3 | $21.71 | 27,731 | $602K | 42.8% |
| Total | $21.89 avg | 64,262 | $1.4M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |